Medicare Enrolled
Dr. Dean Laganosky, M.D.
Urology Physician · Plymouth Meeting, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Laganosky from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Laganosky?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Laganosky
Dr. Dean Laganosky is an urology physician in Plymouth Meeting, PA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Laganosky performed 2,917 Medicare services across 1,995 unique beneficiaries.
Between the years covered by Open Payments, Dr. Laganosky received a total of $24,582 from 49 pharmaceutical and/or device companies across 288 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Laganosky is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 22% volume in PA
$24,582 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,917
Medicare services
Top 22% in PA for urology physician
1,995
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~243 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
564 | $8 | $66 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
535 | $2 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
350 | $94 | $296 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
266 | $62 | $206 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
196 | $0 | $7 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
163 | $49 | $85 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
114 | $41 | $65 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
80 | $8 | $169 |
| Implantable tissue marker, each A small marker is implanted into tissue to serve as a reference point for future medical imaging or procedures. |
66 | $177 | $236 |
| Other procedure on male genital system A surgical or medical intervention performed on the male genital organs that does not fall under other specific categories. |
61 | $118 | $500 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
57 | $68 | $156 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
52 | $63 | $117 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
51 | $124 | $358 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
49 | $63 | $600 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
49 | $113 | $250 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
48 | $45 | $437 |
| Injection of biodegradable material next to prostate A procedure involving the injection of a biodegradable substance into the tissue surrounding the prostate gland. |
48 | $2,417 | $7,500 |
| Prostate radiation therapy device placement A device is placed in the prostate to facilitate radiation therapy. This procedure involves positioning the device to aid in the delivery of radiation treatment. |
47 | $63 | $284 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
47 | $11 | $64 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
31 | $45 | $149 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
30 | $63 | $246 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $40 | $72 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$24,582
Total received (2018-2024)
Avg $3,512/year across 7 years
Top 7% in PA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
288
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$15,729 (64.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,938 (32.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$916 (3.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$13,726
2023
$9,053
2022
$709
2021
$487
2020
$256
2019
$201
2018
$150
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$10,283
BIOPROTECT MEDICAL, INC.
$916
Sumitomo Pharma America, Inc.
$370
Astellas Pharma US Inc
$280
Dendreon Pharmaceuticals LLC
$262
Janssen Biotech, Inc.
$214
PFIZER INC.
$191
AstraZeneca Pharmaceuticals LP
$140
PROGENICS PHARMACEUTICALS, INC.
$130
Tolmar, Inc.
$105
UROGEN PHARMA, INC.
$89
Merck Sharp & Dohme LLC
$84
Bayer Healthcare Pharmaceuticals Inc.
$82
Teleflex LLC
$67
BLUEWIND MEDICAL
$64
Axonics, Inc.
$64
Medtronic, Inc.
$63
ABBVIE INC.
$58
Laborie Medical Technologies Corp.
$54
Ferring Pharmaceuticals Inc.
$41
Telix Pharmaceuticals
$40
PROCEPT BioRobotics Corporation
$38
Novartis Pharmaceuticals Corporation
$38
Astellas Pharma Global Development
$34
Mission Pharmacal Company
$20
Top 3 companies account for 84.3% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$15,569
PROCEPT BioRobotics Corporation
$2,382
BIOPROTECT MEDICAL, INC.
$916
Astellas Pharma US Inc
$608
Dendreon Pharmaceuticals LLC
$471
Janssen Biotech, Inc.
$460
Sumitomo Pharma America, Inc.
$438
PFIZER INC.
$389
Teleflex LLC
$271
Bayer Healthcare Pharmaceuticals Inc.
$270
Axonics, Inc.
$262
Merck Sharp & Dohme LLC
$225
Tolmar, Inc.
$163
NeoTract Inc.
$146
AstraZeneca Pharmaceuticals LP
$140
PROGENICS PHARMACEUTICALS, INC.
$130
Olympus America Inc.
$129
Cook Medical LLC
$127
UROGEN PHARMA, INC.
$109
Laborie Medical Technologies Corp.
$108
UroGen Pharma, Inc.
$90
Bayer HealthCare Pharmaceuticals Inc.
$89
BOSTON SCIENTIFIC CORPORATION
$88
Myriad Genetic Laboratories, Inc.
$75
UROVANT SCIENCES INC
$69
Mission Pharmacal Company
$68
BLUEWIND MEDICAL
$64
Medtronic, Inc.
$63
ABBVIE INC.
$58
Verity Pharmaceuticals Inc.
$53
Palette Life Sciences, Inc.
$52
Agiliti Surgical, Inc.
$46
180 Medical, Inc.
$43
Ferring Pharmaceuticals Inc.
$41
Telix Pharmaceuticals
$40
Novartis Pharmaceuticals Corporation
$38
Astellas Pharma Global Development
$34
Endo Pharmaceuticals Inc.
$33
Progenics Pharmaceuticals, Inc.
$32
E.R. Squibb & Sons, L.L.C.
$29
DENTSPLY IH AB
$28
Myovant Sciences Inc.
$27
Blue Earth Diagnostics Limited
$23
Biocompatibles, Inc.
$22
Alnylam Pharmaceuticals Inc.
$15
TOLMAR Pharmaceuticals, Inc.
$15
CONMED Corporation
$14
Sun Pharmaceutical Industries Inc.
$13
Retrophin, Inc.
$4
Top 3 companies account for 76.8% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ABIRATERONE ACETATE · ADSTILADRIN · AIRSEAL · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · Axonics · Axonics r-SNM System · BIOPROTECT BALLOON IMPLANT SYSTEM · BOTOX · Cook Medical Lasers · ELIGARD · ERLEADA · GEMTESA · GENERAL UTERINE TISSUE REMOVAL · GENERAL - ONCOLOGY · GENTLECATH · ILLUCCIX · IMFINZI · INFUGEM · INTERSTIM · JELMYTO · KEYTRUDA · LYNPARZA · LoFric · MYRBETRIQ · Myrbetriq · Nubeqa · OPDIVO · ORGOVYX · OXLUMO · Optilume BPH Drug Coated Balloon Catheter · PLUVICTO · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Prolaris · REVI · REZUM · Rezum Generator · SOLESTA · SPACEOAR VUE · Sonablate · SpaceOAR System · SpaceOAR VUE System - 10mL · Trelstar · URIBEL · URIBEL TABS · UROLIFT · Uribel · UroLift · UroLift System · VISUAL-ICE · XIAFLEX · XTANDI · Xofigo · Xtandi · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (64%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for urology physician in PA.
Geographic Context
Urology physicians within 10 mi
282
Per 100K population
32.7
County median income
$111,521
Nearest hospital
SUBURBAN COMMUNITY HOSPITAL
2.8 mi
2.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Laganosky is a clinical cardiology specialist, with above-average Medicare volume (top 22% in PA), with speaking/promotional industry engagement in the top 7% of PA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Laganosky experienced with bladder ultrasound after voiding?
Based on Medicare claims data, Dr. Laganosky performed 564 bladder ultrasound after voiding services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Laganosky receive payments from pharmaceutical companies?
Yes. Dr. Laganosky received a total of $24,582 from 49 companies across 288 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Laganosky's costs compare to other urology physicians in Plymouth Meeting?
Dr. Laganosky's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Laganosky) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Plymouth Meeting
Browse urology physicians in Plymouth Meeting ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in PA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in PA
Which PA urology physicians receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
PROCEPT BioRobotics Corporation Payments to Doctors
See all physicians who received payments from PROCEPT BioRobotics Corporation.
By company
BIOPROTECT MEDICAL, INC. Payments to Doctors
See all physicians who received payments from BIOPROTECT MEDICAL, INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology